At UCB, we come together to work, laser-focused, on a simple question: How will this create value for people living with severe diseases? Patient value is not just what we say, but how we live. How we do business – from discovery to development to delivery – has been transformed and redesigned around the patient’s individual experience. Patients are at the heart of everything we do, inspiring us and driving our scientific discovery. By fulfilling our commitment and providing patients a meaningful experience, more impactful solutions are on the horizon. With a team of approximately 8,300 employees and operations in nearly 40 countries, we are a global biopharmaceutical company investing more than a quarter of our revenue in cutting-edge scientific research. Global headquarters are in Brussels, Belgium, with U.S. headquarters in Atlanta, Georgia and sites in Raleigh and Durham, North Carolina, Boston, Massachusetts, Seattle, Washington, and Washington, D.C.
At UCB, we come together everyday laser-focused on a simple question: How will this create value for people living with severe diseases? We are a global biopharmaceutical company committed to innovation to improve the lives of people with neurological and immunological diseases, finding solutions to meet their unique needs.
Brands:BRIVIACT, NAYZILAM, FINTEPLA